8-KItem 1.01 · Material AgreementItem 1.02 · Termination of AgreementItem 2.03 · Financial ObligationItem 9.01 · Financial Statements
West Pharmaceutical Services References Agreement in Item 2.03 Filing
Filed with the SEC on · Summarized by InvestorsBot
West Pharmaceutical Services disclosed that the information in Item 2.03, concerning creation of a direct financial obligation, is incorporated into this Item 1.01 filing. The provided disclosure does not include the counterparty, terms, amount, shareholder impact or next steps.